Your browser doesn't support javascript.
loading
Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma.
Wu, Shuai; Fukumoto, Takeshi; Lin, Jianhuang; Nacarelli, Timothy; Wang, Yemin; Ong, Dionzie; Liu, Heng; Fatkhutdinov, Nail; Zundell, Joseph A; Karakashev, Sergey; Zhou, Wei; Schwartz, Lauren E; Tang, Hsin-Yao; Drapkin, Ronny; Liu, Qin; Huntsman, David G; Kossenkov, Andrew V; Speicher, David W; Schug, Zachary T; Van Dang, Chi; Zhang, Rugang.
Afiliación
  • Wu S; Immunology, Microenvironment & Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
  • Fukumoto T; Immunology, Microenvironment & Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
  • Lin J; Immunology, Microenvironment & Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
  • Nacarelli T; Immunology, Microenvironment & Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
  • Wang Y; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Ong D; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Liu H; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Fatkhutdinov N; Immunology, Microenvironment & Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
  • Zundell JA; Immunology, Microenvironment & Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
  • Karakashev S; Immunology, Microenvironment & Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
  • Zhou W; Immunology, Microenvironment & Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
  • Schwartz LE; Immunology, Microenvironment & Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
  • Tang HY; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Drapkin R; Proteomics and Metabolomics Facility, The Wistar Institute, Philadelphia, PA, USA.
  • Liu Q; Department of Obstetrics and Gynecology, Penn Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Huntsman DG; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, USA.
  • Kossenkov AV; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Speicher DW; Immunology, Microenvironment & Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.
  • Schug ZT; Proteomics and Metabolomics Facility, The Wistar Institute, Philadelphia, PA, USA.
  • Van Dang C; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, USA.
  • Zhang R; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, USA.
Nat Cancer ; 2(2): 189-200, 2021 02.
Article en En | MEDLINE | ID: mdl-34085048
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Adenocarcinoma de Células Claras Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Nat Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Adenocarcinoma de Células Claras Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Nat Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido